Marinomed Biotech AG Profit Margin

As of the most recent data (March 2025), MARI.VI shows a profit margin of 91.61%. That compares with -54.8% in the prior-year period — up 267.2% year over year. That is above the Healthcare sector average of 10.58%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MARI.VI's profit margin is now 91.61% (was -54.8%) — a 267.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Marinomed Biotech AG is outperforming or lagging.

The Healthcare sector average profit margin is about 10.58%. Marinomed Biotech AG is at 91.61%, which is higher that average. That is roughly 765.8% above the sector mean. Use the comparison chart on this page to see how MARI.VI stacks up against individual peers as well.

That compares with -54.8% in the prior-year period — up 267.2% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Marinomed Biotech AG with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Marinomed Biotech AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 91.61%) with ownership activity and broader fundamentals.